Single-Dose Carboplatin Followed by Involved-Node Radiotherapy for Stage IIA and IIB Seminoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Lancet Oncol 2022 Oct 10;[EPub Ahead of Print], A Papachristofilou, J Bedke, S Hayoz, U Schratzenstaller, M Pless, M Hentrich, S Krege, A Lorch, DM Aebersold, PM Putora, DR Berthold, D Zihler, F Zengerling, A Dieing, AC Mueller, C Schaer, C Biaggi, S Gillessen, R CathomasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.